Company profile
Ascend Wellness Holdings, Inc.
OTC: AAWH · Healthcare · Drug Manufacturers - Specialty & Generic
PublicHQ Morristown, NYCIK 0001756390Reports USD
#215 of 1,418 Healthcare companies by revenue32nd-percentile growth
EA Score
53DFH 61DQ 44GM 46SS 58
v0.1 · 65/100 weight · provisional
↑ workforce scale, operating margin · ↓ listing tenure, disclosure history
Methodology →Revenue TTM
$489.5M
Rev growth YoY (TTM)
-10.5%
Net income (FY)
-$118.2M
Employees
2,300
as of 2026-09-15
Market cap
$109.0M
as of 2026-09-15
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$500.6M$500.6M2025
Net income-$118.2M-$118.2M2025
Operating income-$17.0M-$17.0M2025
Total assets$907.9M$907.9M2025
Liabilities$954.5M$954.5M2025
Equity-$47.4M-$47.4M2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Retail100%
By geography
Not disclosed.
The read
What is Ascend Wellness Holdings, Inc.’s revenue?
Ascend Wellness Holdings, Inc. booked $500.6M in FY2025 revenue, contracting 11% year over year — slower than 68% of Healthcare companies we track, at a -23.6% net margin.
Peers · Healthcare
The Oncology Institute, Inc.52DOncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst59CBridgeBio Pharma, Inc.52DInyx, Inc.——Travere Therapeutics, Inc.74BPhreesia, Inc.68BKey facts
CEOSamuel Brill
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersMorristown, NY
ExchangeOTC: AAWH
Employees2,300
IPO date2021-05-26
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.